JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
iShares Russell 2000 ETF
IWM
$77.1B
| $1.58B | 0.35% |
10,703,143
-2,252,292
| -17% | -$317M |
2013 Q2
17 quarters
|
|
52
Mondelez International
MDLZ
$77.4B
| $1.54B | 0.34% |
38,084,438
-842,210
| -2% | -$35.8M |
2013 Q2
17 quarters
|
|
53
NVIDIA
NVDA
$5.57T
| $1.51B | 0.33% |
344,208,400
+31,258,520
| +10% | +$130M |
2013 Q2
17 quarters
|
|
54
MetLife
MET
$62.6B
| $1.51B | 0.33% |
29,389,750
+3,028,823
| +11% | +$148M |
2013 Q2
17 quarters
|
|
55
Boston Scientific
BSX
$60.9B
| $1.5B | 0.33% |
52,333,964
-2,068,519
| -4% | -$57.1M |
2013 Q2
17 quarters
|
|
56
Xcel Energy
XEL
$45.8B
| $1.44B | 0.32% |
30,317,644
+1,810,629
| +6% | +$86.9M |
2013 Q2
17 quarters
|
|
57
Analog Devices
ADI
$197B
| $1.43B | 0.32% |
16,692,851
+213,714
| +1% | +$17.2M |
2013 Q2
17 quarters
|
|
58
Bristol-Myers Squibb
BMY
$122B
| $1.42B | 0.31% |
22,534,141
-10,214
| -0% | -$596K |
2013 Q2
17 quarters
|
|
59
Capital One
COF
$122B
| $1.41B | 0.31% |
16,765,401
+1,327,711
| +9% | +$109M |
2013 Q2
17 quarters
|
|
60
Delta Air Lines
DAL
$54B
| $1.41B | 0.31% |
29,118,831
+39,522
| +0.1% | +$1.97M |
2013 Q2
17 quarters
|
|
61
Mastercard
MA
$503B
| $1.4B | 0.31% |
10,019,266
-921,166
| -8% | -$122M |
2013 Q2
17 quarters
|
|
62
Hartford Financial Services
HIG
$35.1B
| $1.4B | 0.31% |
25,416,707
-4,654,191
| -15% | -$253M |
2013 Q2
17 quarters
|
|
63
Northrop Grumman
NOC
$68.8B
| $1.4B | 0.31% |
4,921,189
+777,899
| +19% | +$209M |
2013 Q2
17 quarters
|
|
64
Vertex Pharmaceuticals
VRTX
$128B
| $1.39B | 0.31% |
9,322,447
+939,894
| +11% | +$141M |
2013 Q2
17 quarters
|
|
65
Verizon
VZ
$193B
| $1.38B | 0.3% |
27,921,128
+2,595,029
| +10% | +$122M |
2013 Q2
17 quarters
|
|
66
GE Aerospace
GE
$317B
| $1.37B | 0.3% |
11,824,991
-3,535,103
| -23% | -$427M |
2014 Q3
12 quarters
|
|
67
iShares MSCI Japan ETF
EWJ
$23.8B
| $1.36B | 0.3% |
24,504,244
-1,406,754
| -5% | -$76.7M |
2013 Q2
17 quarters
|
|
68
Charter Communications
CHTR
$12.6B
| $1.35B | 0.3% |
3,746,033
-224,680
| -6% | -$83.6M |
2013 Q2
17 quarters
|
|
69
American International
AIG
$40.3B
| $1.33B | 0.29% |
21,742,660
-243,194
| -1% | -$15.2M |
2013 Q2
17 quarters
|
|
|
WBA
70
DELISTED
Walgreens Boots Alliance
WBA
| $1.3B | 0.29% |
16,805,197
-167,600
| -1% | -$13.4M |
2013 Q2
17 quarters
|
|
|
DISH
71
DELISTED
DISH Network Corp.
DISH
| $1.27B | 0.28% |
23,875,716
-176,165
| -0.7% | -$10.4M |
2013 Q2
17 quarters
|
|
72
IBM
IBM
$213B
| $1.24B | 0.27% |
8,934,225
+3,029,731
| +51% | +$422M |
2013 Q2
17 quarters
|
|
73
AT&T
T
$170B
| $1.24B | 0.27% |
42,149,901
-6,117,364
| -13% | -$174M |
2013 Q2
17 quarters
|
|
74
HDFC Bank
HDB
$113B
| $1.22B | 0.27% |
51,077,352
-4,872,548
| -9% | -$116M |
2013 Q2
17 quarters
|
|
|
CELG
75
DELISTED
Celgene Corp
CELG
| $1.21B | 0.27% |
8,501,042
-503,470
| -6% | -$68.6M |
2013 Q2
17 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.